See more : Integrated Diagnostics Holdings plc (IDHC.L) Income Statement Analysis – Financial Results
Complete financial analysis of Canature Health Technology Co., Ltd. (300272.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Canature Health Technology Co., Ltd., a leading company in the Industrial – Pollution & Treatment Controls industry within the Industrials sector.
- Ryanair Holdings plc (RYAAY) Income Statement Analysis – Financial Results
- Chino Commercial Bancorp (CCBC) Income Statement Analysis – Financial Results
- Stolt-Nielsen Limited (0OHK.L) Income Statement Analysis – Financial Results
- Aardvark Ventures Inc. (ROCAF) Income Statement Analysis – Financial Results
- Kyoto Tool Co., Ltd. (5966.T) Income Statement Analysis – Financial Results
Canature Health Technology Co., Ltd. (300272.SZ)
Industry: Industrial - Pollution & Treatment Controls
Sector: Industrials
Website: https://www.canature.com
About Canature Health Technology Co., Ltd.
Canature Health Technology Co., Ltd. engages in the research, development, manufacture, production of residential water treatment products in China, the Middle East, Europe, rest of Asia, North America, and internationally. Its products include whole-house water purifiers and softeners, commercial purified water dispensers, membrane reverse osmosis water purifiers, multi-way control valves, and composite pressure vessels. The company was formerly known as Shanghai Canature Environmental Products Co., Ltd. and changed its name to Canature Health Technology Co., Ltd. in July 2018. Canature Health Technology Co., Ltd. was founded in 2001 and is headquartered in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.67B | 1.66B | 1.51B | 1.18B | 1.05B | 901.02M | 707.50M | 643.00M | 456.84M | 374.74M | 311.21M | 240.72M | 207.07M | 165.04M | 124.94M | 96.04M | 80.61M |
| Cost of Revenue | 1.06B | 1.10B | 1.01B | 665.35M | 587.69M | 550.25M | 442.43M | 403.92M | 272.57M | 226.98M | 180.71M | 133.81M | 115.35M | 87.08M | 65.75M | 54.16M | 45.22M |
| Gross Profit | 615.87M | 563.83M | 505.39M | 515.78M | 464.83M | 350.77M | 265.07M | 239.07M | 184.27M | 147.76M | 130.50M | 106.91M | 91.72M | 77.96M | 59.19M | 41.88M | 35.38M |
| Gross Profit Ratio | 36.84% | 33.95% | 33.44% | 43.67% | 44.16% | 38.93% | 37.47% | 37.18% | 40.34% | 39.43% | 41.93% | 44.41% | 44.30% | 47.24% | 47.38% | 43.60% | 43.89% |
| Research & Development | 67.42M | 66.82M | 54.59M | 35.87M | 18.79M | 34.78M | 40.90M | 26.46M | 22.72M | 12.17M | 8.41M | 7.53M | 5.67M | 4.80M | 3.14M | 2.77M | 0.00 |
| General & Administrative | 35.16M | 33.73M | 26.88M | 29.44M | 34.21M | 35.05M | 30.77M | 21.83M | 15.40M | 7.47M | 9.25M | 8.79M | 6.01M | 5.74M | 5.60M | 5.51M | 10.06M |
| Selling & Marketing | 76.93M | 150.55M | 132.71M | 172.19M | 165.72M | 130.37M | 92.22M | 57.12M | 42.33M | 34.34M | 30.66M | 25.28M | 18.48M | 14.01M | 10.86M | 10.91M | 9.91M |
| SG&A | 386.22M | 184.28M | 159.59M | 201.62M | 199.94M | 165.42M | 123.00M | 78.96M | 57.72M | 41.81M | 39.91M | 34.08M | 24.49M | 19.75M | 16.45M | 16.42M | 19.96M |
| Other Expenses | 432.29K | 8.63M | -9.12M | 18.96M | 18.10M | 16.40M | 11.49M | 10.31M | 4.77M | 2.42M | 3.10M | 3.73M | 1.31M | 1.88M | 857.13K | 98.16K | 165.45K |
| Operating Expenses | 454.07M | 420.52M | 355.49M | 352.15M | 341.11M | 289.85M | 235.08M | 155.55M | 110.81M | 74.32M | 65.83M | 57.52M | 43.11M | 34.79M | 28.63M | 27.52M | 20.23M |
| Cost & Expenses | 1.51B | 1.52B | 1.36B | 1.02B | 928.80M | 840.11M | 677.51M | 559.48M | 383.38M | 301.30M | 246.53M | 191.33M | 158.46M | 121.87M | 94.38M | 81.68M | 65.45M |
| Interest Income | 14.87M | 5.54M | 1.29M | 636.62K | 1.62M | 2.00M | 4.54M | 1.47M | 1.58M | 2.11M | 3.33M | 8.58M | 609.61K | 275.82K | 342.03K | 294.29K | -0.50 |
| Interest Expense | 32.58M | 16.85M | 16.28M | 15.05M | 13.87M | 8.60M | 11.23M | 5.75M | 438.64K | 1.94M | 360.21K | 323.32K | 1.36M | 1.19M | 804.25K | 498.11K | 1.98M |
| Depreciation & Amortization | 76.91M | 80.33M | 63.72M | 46.53M | 34.46M | 39.71M | 65.48M | 40.39M | 17.65M | 11.27M | 9.10M | 7.33M | 6.54M | 5.88M | 4.65M | 3.69M | 2.92M |
| EBITDA | 264.16M | 206.88M | 242.57M | 118.67M | 232.08M | 440.83M | 85.99M | 153.26M | 112.62M | 82.59M | 73.77M | 67.64M | 55.39M | 50.37M | 36.13M | 18.02M | 18.07M |
| EBITDA Ratio | 15.80% | 13.77% | 14.49% | 17.37% | 20.26% | 46.44% | 16.18% | 23.20% | 24.07% | 23.17% | 24.17% | 28.40% | 27.08% | 30.73% | 29.01% | 18.89% | 22.28% |
| Operating Income | 161.81M | 113.00M | 152.19M | 46.60M | 158.73M | 360.91M | 10.13M | 94.96M | 82.13M | 78.41M | 65.78M | 56.69M | 46.17M | 41.45M | 29.82M | 13.73M | 13.29M |
| Operating Income Ratio | 9.68% | 6.80% | 10.07% | 3.95% | 15.08% | 40.06% | 1.43% | 14.77% | 17.98% | 20.92% | 21.14% | 23.55% | 22.30% | 25.12% | 23.87% | 14.30% | 16.49% |
| Total Other Income/Expenses | -3.00M | 1.27M | -6.69M | 20.66M | 18.56M | 16.40M | 11.49M | 9.84M | 4.69M | 2.41M | 3.07M | 11.54M | -172.71K | 434.21K | 233.43K | -402.32K | 160.60K |
| Income Before Tax | 158.81M | 114.27M | 145.49M | 66.30M | 177.28M | 377.31M | 21.63M | 104.79M | 86.83M | 80.82M | 68.85M | 60.31M | 47.48M | 43.30M | 30.68M | 13.83M | 13.46M |
| Income Before Tax Ratio | 9.50% | 6.88% | 9.63% | 5.61% | 16.84% | 41.88% | 3.06% | 16.30% | 19.01% | 21.57% | 22.12% | 25.06% | 22.93% | 26.24% | 24.55% | 14.40% | 16.69% |
| Income Tax Expense | 5.33M | 14.85M | 28.39M | 15.78M | 56.83M | 28.01M | 10.78M | 15.59M | 10.82M | 12.54M | 10.58M | 9.85M | 7.43M | 6.58M | 3.93M | 1.22M | 2.01M |
| Net Income | 132.45M | 92.56M | 104.86M | 26.42M | 100.51M | 348.01M | 58.01M | 90.25M | 76.01M | 64.24M | 56.97M | 49.80M | 39.73M | 36.48M | 26.27M | 12.22M | 11.35M |
| Net Income Ratio | 7.92% | 5.57% | 6.94% | 2.24% | 9.55% | 38.62% | 8.20% | 14.04% | 16.64% | 17.14% | 18.31% | 20.69% | 19.19% | 22.10% | 21.02% | 12.72% | 14.08% |
| EPS | 0.24 | 0.17 | 0.18 | 0.05 | 0.17 | 0.61 | 0.10 | 0.16 | 0.13 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.06 | 0.03 | 0.00 |
| EPS Diluted | 0.23 | 0.17 | 0.18 | 0.05 | 0.17 | 0.61 | 0.10 | 0.16 | 0.13 | 0.11 | 0.10 | 0.09 | 0.09 | 0.09 | 0.06 | 0.03 | 0.00 |
| Weighted Avg Shares Out | 551.86M | 561.70M | 567.17M | 528.35M | 574.93M | 570.51M | 573.39M | 565.04M | 567.39M | 564.32M | 570.60M | 559.37M | 447.58M | 424.94M | 420.72M | 417.49M | 0.00 |
| Weighted Avg Shares Out (Dil) | 575.86M | 561.70M | 567.17M | 528.35M | 574.93M | 570.51M | 580.10M | 565.04M | 568.86M | 578.13M | 570.60M | 559.37M | 447.58M | 424.94M | 420.72M | 417.49M | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports